ロード中...
The treatment of chronic progressive multiple sclerosis with cladribine.
A 2-year, placebo-controlled, double-blind, crossover study was started in 1992 to evaluate cladribine, an immunosuppressive drug, in the treatment of chronic progressive multiple sclerosis. In the first year patients were given cladribine 0.10 mg/kg per day for 7 days as four monthly courses for a...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1996
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC40008/ https://ncbi.nlm.nih.gov/pubmed/8643695 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|